PCN87 The Cost Effectiveness of Cetuximab (Erbitux) in the Third Line Treatment of Metastatic Colorectal Cancer in the UK
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1188
https://www.valueinhealthjournal.com/article/S1098-3015(11)02750-1/fulltext
Title :
PCN87 The Cost Effectiveness of Cetuximab (Erbitux) in the Third Line Treatment of Metastatic Colorectal Cancer in the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02750-1&doi=10.1016/j.jval.2011.08.1188
First page :
A450
Section Title :
Cancer
Open access? :
No
Section Order :
1148